Association Between Chronic Obstructive Pulmonary Disease and Type 2 Diabetes: A Systematic Review and Meta-Analysis

References

• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365.
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968.
   PubMed Web of Science ®Google Scholar
• From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2017. https://goldcopd.org.
   Google Scholar
• van der Molen T. Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences. Prim Care Respir J. 2010;19(4):326–334.
   PubMedGoogle Scholar
• Martinez FD. Early-life origins of chronic obstructive pulmonary disease. N Engl J Med. 2016;375(9):871–878.
   PubMed Web of Science ®Google Scholar
• Omland O, Wurtz ET, Aasen TB, et al. Occupational chronic obstructive pulmonary disease: a systematic literature review. Scand J Work Environ Health. 2014;40(1):19–35. doi:10.5271/sjweh.3400.
   PubMed Web of Science ®Google Scholar
• Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Global Health. 2015;5(2):020415.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Burden of COPD. http://www.who.int/respiratory/copd/burden/en/. Accessed September 20, 2018.
   Google Scholar
• Rodríguez-González Moro JM, Izquierdo IJ, Antón E, de Lucas P, Martín A; MUVICE Study Group. Health-related quality of life in outpatient women with COPD in daily practice: the MUVICE Spanish study. Respir Med. 2009:103(9):1303–1312.
   PubMed Web of Science ®Google Scholar
• Bloom DE, Cafiero ET, Jané-Llopis E, et al. The Global Economic Burden of Non-communicable Diseases. Geneva: World Economic Forum. A report by the World Economic Forum and the Harvard School of Public Health; 2011.
   Google Scholar
• Mannino DM, Higuchi K, Yu TC, et al. Economic burden of COPD in the presence of comorbidities. Chest 2015;148(1):138–150.
   PubMed Web of Science ®Google Scholar
• McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007;62(5):411–415.
   PubMed Web of Science ®Google Scholar
• Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study. Lancet 1999;353(9165):1649–1652.
   PubMed Web of Science ®Google Scholar
• Bolton CE, Ionescu AA, Shiels KM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(12):1286–1293.
   PubMed Web of Science ®Google Scholar
• Decramer M, Rennard S, Troosters T, et al. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention. COPD 2008;5(4):235–256. doi:10.1080/15412550802237531.
   PubMedGoogle Scholar
• Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med. 1999;159(4 Pt 2):S1–S40.
   PubMed Web of Science ®Google Scholar
• Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21(2):347–360. doi:10.1183/09031936.03.00405703.
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007;370(9589):797–799.
   PubMed Web of Science ®Google Scholar
• Meteran H, Backer V, Kyvik KO, Skytthe A, Thomsen SF. Comorbidity between chronic obstructive pulmonary disease and type 2 diabetes: a nation-wide cohort twin study. Respir Med. 2015;109(8):1026–1030.
   PubMed Web of Science ®Google Scholar
• Glaser S, Kruger S, Merkel M, Bramlage P, Herth FJ. Chronic obstructive pulmonary disease and diabetes mellitus: a systematic review of the literature. Respiration 2015;89(3):253–264. doi:10.1159/000369863.
   PubMed Web of Science ®Google Scholar
• Roglic G; World Health Organization. Global Report on Diabetes. Geneva, Switzerland: World Health Organization; 2016.
   Google Scholar
• Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003;52(7):1799–1805. doi:10.2337/diabetes.52.7.1799.
   PubMed Web of Science ®Google Scholar
• Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151.
   PubMed Web of Science ®Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
   PubMed Web of Science ®Google Scholar
• Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. PharmacoEconomics 2015;33(8):811–831.
   PubMed Web of Science ®Google Scholar
• Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153(2):530–534. doi:10.1164/ajrccm.153.2.8564092.
   PubMed Web of Science ®Google Scholar
• Lee CT, Mao IC, Lin CH, Lin SH, Hsieh MC. Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population-based study. Eur J Clin Invest. 2013;43(11):1113–1119.
   PubMed Web of Science ®Google Scholar
• Lindberg A, Larsson LG, Ronmark E, Lundback B. Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function. COPD 2011;8(6):421–428.
   PubMedGoogle Scholar
• Rana JS, Mittleman MA, Sheikh J, et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care. 2004;27(10):2478–2484. doi:10.2337/diacare.27.10.2478.
   PubMed Web of Science ®Google Scholar
• Song Y, Klevak A, Manson JE, Buring JE, Liu S. Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women's Health Study. Diabetes Res Clin Pract. 2010;90(3):365–371. doi:10.1016/j.diabres.2010.09.010.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http://wwwohrica/programs/clinical_epidemiology/oxford.htm, Published 2009. Accessed September 20, 2018.
   Google Scholar
• Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S. Cochrane Handbook for systematic reviews of interventions version 5.1.0: The Cochrane Collaboration. http://handbook.cochrane.org/, Published 2011; Updated March 2011. Accessed September 20, 2018.
   Google Scholar
• Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003;326(7382):219.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010;65(11):956–962. doi:10.1136/thx.2009.128082.
   PubMed Web of Science ®Google Scholar
• Joo H, Park J, Lee SD, Oh YM. Comorbidities of chronic obstructive pulmonary disease in Koreans: a population-based study. J Korean Med Sci. 2012;27(8):901–906. doi:10.3346/jkms.2012.27.8.901.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0: The Cochrane Collaboration. Published 2011; Updated March 2011. http://handbook.cochrane.org/.
   Google Scholar
• Goldman N, Lin IF, Weinstein M, Lin YH. Evaluating the quality of self-reports of hypertension and diabetes. J Clin Epidemiol. 2003;56(2):148–154.
   PubMed Web of Science ®Google Scholar
• Meteran H, Miller MR, Thomsen SF, Christensen K, Sigsgaard T, Backer V. The impact of different spirometric definitions on the prevalence of airway obstruction and their association with respiratory symptoms. ERJ Open Res. 2017;3(4).
   PubMedGoogle Scholar
• Sode BF, Dahl M, Nordestgaard BG. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. Eur Heart J. 2011;32(19):2365–2375. doi:10.1093/eurheartj/ehr338.
   PubMed Web of Science ®Google Scholar
• Cazzola M, Bettoncelli G, Sessa E, Cricelli C, Biscione G. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration 2010;80(2):112–119.
   PubMed Web of Science ®Google Scholar
• Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286(3):327–334.
   PubMed Web of Science ®Google Scholar
• Spranger J, Kroke A, Mohlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003;52(3):812–817. doi:10.2337/diabetes.52.3.812.
   PubMed Web of Science ®Google Scholar
• Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59(7):574–80. doi:10.1136/thx.2003.019588.
   PubMed Web of Science ®Google Scholar
• Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23(5):599–622.
   PubMed Web of Science ®Google Scholar
• MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):50–60. doi:10.1513/pats.200411-056SF.
   PubMedGoogle Scholar
• Pallayova M, Lazurova I, Donic V. Hypoxic damage to pancreatic beta cells--the hidden link between sleep apnea and diabetes. Med Hypotheses. 2011;77(5):930–934.
   PubMed Web of Science ®Google Scholar
• Spies CM, Strehl C, van der Goes MC, Bijlsma JWJ, Buttgereit F. Glucocorticoids. Best Pract Res Clin Rheumatol. 2011;25(6):891–900. doi:10.1016/j.berh.2011.11.002.
   PubMed Web of Science ®Google Scholar
• Herth FJ, Bramlage P, Muller-Wieland D. Current perspectives on the contribution of inhaled corticosteroids to an increased risk for diabetes onset and progression in patients with chronic obstructive pulmonary disease. Respiration 2015;89(1):66–75. doi:10.1159/000368371.
   PubMed Web of Science ®Google Scholar
• Pelaia G, Vatrella A, Cuda G, Maselli R, Marsico SA. Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. Life Sci. 2003;72(14):1549–1561.
   PubMed Web of Science ®Google Scholar
• Suissa S, Kezouh A, Ernst P. Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med. 2010;123(11):1001–1006.
   PubMed Web of Science ®Google Scholar
• Price DB, Russell R, Mares R, et al. Metabolic effects associated with ICS in patients with COPD and comorbid type 2 diabetes: a historical matched cohort study. PLoS One. 2016;11(9):e0162903. doi:10.1371/journal.pone.0162903.
   PubMed Web of Science ®Google Scholar
• Slatore CG, Bryson CL, Au DH. The association of inhaled corticosteroid use with serum glucose concentration in a large cohort. Am J Med. 2009;122(5):472–428. doi:10.1016/j.amjmed.2008.09.048.
   PubMed Web of Science ®Google Scholar
• Hersh CP, Miller DT, Kwiatkowski DJ, Silverman EK. Genetic determinants of C-reactive protein in COPD. Eur Respir J. 2006; 28(6):1156–1162.
   PubMed Web of Science ®Google Scholar